Skip to main content

Advertisement

SpringerLink
Log in

Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Diuretic therapy is important in critically ill patients because fluid overload impairs organ function and increases mortality. Compared to intermittent administration, continuous infusion of loop diuretics is theoretically superior in terms of diuresis and electrolyte balance. However, the available evidence is susceptible to carryover diuretic effects and resistance in earlier crossover trials. Consequently, we conducted a systematic review and meta-analysis of parallel-group randomized controlled trials to compare these two strategies in adults with acute decompensated heart failure. We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials from their inceptions to May 26, 2018. We pooled the data using a random effects model. Our primary outcomes were all-cause mortality, length of hospital stay, and body weight reduction. We analyzed 12 parallel-group randomized controlled trials involving 923 patients. Compared with intermittent administration, continuous infusion of furosemide was not associated with an improvement in all-cause mortality (risk ratio 1.19; 95% confidence interval [CI], 0.65 to 2.16), length of hospital stay (weighted mean difference [WMD] − 0.88 days; 95% CI, − 2.76 to 1.01), or 24-h urine output (WMD 489.17 mL; 95% CI, − 183.18 to 1161.51), but was significantly associated with a greater body weight reduction (WMD 0.63 kg; 95% CI, 0.23 to 1.02). No differences in hypokalemia, hyponatremia, increased serum creatinine level, and hypotension were noted. Continuous infusion of furosemide, compared to intermittent administration, is associated with a greater body weight reduction and potential increase in 24-h urine output. The limited available evidence suggests no difference in adverse events between both strategies. Trial registration: PROSPERO (CRD42017083878)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ADHF :

Acute decompensated heart failure

CI:

Confidence interval

RR:

Risk ratio

WMD:

Weighted mean difference

References

  1. Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X (2013) Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med 41(2):472–480. https://doi.org/10.1097/CCM.0b013e31826ab377

    Article  PubMed  Google Scholar 

  2. Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL, Sepsis Occurrence in Acutely Ill Patients I (2008) A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care (London, England) 12(3):R74. https://doi.org/10.1186/cc6916

    Article  Google Scholar 

  3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely Ill Patients I (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34(2):344–353

    Article  PubMed  Google Scholar 

  4. Prowle JR, Kirwan CJ, Bellomo R (2014) Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 10(1):37–47. https://doi.org/10.1038/nrneph.2013.232

    Article  CAS  PubMed  Google Scholar 

  5. Silversides JA, Major E, Ferguson AJ, Mann EE, McAuley DF, Marshall JC, Blackwood B, Fan E (2017) Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med 43(2):155–170. https://doi.org/10.1007/s00134-016-4573-3

    Article  PubMed  Google Scholar 

  6. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N (2014) Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 46(5):361–380. https://doi.org/10.5603/ait.2014.0060

    Article  PubMed  Google Scholar 

  7. National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354(24):2564–2575. https://doi.org/10.1056/NEJMoa062200

    Article  Google Scholar 

  8. Jones SL, Martensson J, Glassford NJ, Eastwood GM, Bellomo R (2015) Loop diuretic therapy in the critically ill: a survey. Crit Care Resusc 17(3):223–226

    PubMed  Google Scholar 

  9. Rocha BM, Menezes Falcao L (2016) Acute decompensated heart failure (ADHF): a comprehensive contemporary review on preventing early readmissions and postdischarge death. Int J Cardiol 223:1035–1044. https://doi.org/10.1016/j.ijcard.2016.07.259

    Article  PubMed  Google Scholar 

  10. Wakelkamp M, Alvan G, Gabrielsson J, Paintaud G (1996) Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration. Clin Pharmacol Ther 60(1):75–88. https://doi.org/10.1016/s0009-9236(96)90170-8

    Article  CAS  PubMed  Google Scholar 

  11. Hammarlund MM, Odlind B, Paalzow LK (1985) Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 233(2):447–453

    CAS  PubMed  Google Scholar 

  12. Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96(3–4):132–143

    Article  CAS  PubMed  Google Scholar 

  13. Copeland JG, Campbell DW, Plachetka JR, Salomon NW, Larson DF (1983) Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 146(6):796–799

    Article  CAS  PubMed  Google Scholar 

  14. Aaser E, Gullestad L, Tollofsrud S, Lundberg J, Hall C, Djoseland O, Kjekshus J, Forfang K (1997) Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 57(4):361–367

    Article  CAS  PubMed  Google Scholar 

  15. Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28(2):376–382. https://doi.org/10.1016/0735-1097(96)00161-1

    Article  CAS  PubMed  Google Scholar 

  16. Kramer WG, Smith WB, Ferguson J, Serpas T, Grant AG 3rd, Black PK, Brater DC (1996) Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol 36(3):265–270

    Article  CAS  PubMed  Google Scholar 

  17. Lahav M, Regev A, Ra’anani P, Theodor E (1992) Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 102(3):725–731

    Article  CAS  PubMed  Google Scholar 

  18. Pivac N, Rumboldt Z, Sardelic S, Bagatin J, Polic S, Ljutic D, Naranca M, Capkun V (1998) Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res 18(3):121–128

    CAS  PubMed  Google Scholar 

  19. Amer M, Adomaityte J, Qayyum R (2012) Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials. J Hosp Med 7(3):270–275. https://doi.org/10.1002/jhm.991

    Article  PubMed  Google Scholar 

  20. Salvador DR, Rey NR, Ramos GC, Punzalan FE (2005) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev (3):CD003178. https://doi.org/10.1002/14651858.CD003178.pub3

  21. Wu MY, Chang NC, Su CL, Hsu YH, Chen TW, Lin YF, Wu CH, Tam KW (2014) Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials. J Crit Care 29(1):2–9. https://doi.org/10.1016/j.jcrc.2013.10.009

    Article  PubMed  Google Scholar 

  22. Higgins J, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley cochrane series, 1st edn. Wiley, Chichester

    Book  Google Scholar 

  23. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535

    Article  PubMed  PubMed Central  Google Scholar 

  24. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane Statistical Methods G (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sweeting MJ, Sutton AJ, Lambert PC (2004) What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 23(9):1351–1375. https://doi.org/10.1002/sim.1761

    Article  PubMed  Google Scholar 

  26. Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135

    Article  PubMed  PubMed Central  Google Scholar 

  27. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  28. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  29. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O’Connor CM (2010) Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure. Am J Cardiol 105(12):1794–1797. https://doi.org/10.1016/j.amjcard.2010.01.355

    Article  PubMed  PubMed Central  Google Scholar 

  31. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM, Network NHFCR (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805. https://doi.org/10.1056/NEJMoa1005419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Llorens P, Miro O, Herrero P, Martin-Sanchez FJ, Jacob J, Valero A, Alonso H, Perez-Dura MJ, Noval A, Gil-Roman JJ, Zapater P, Llanos L, Gil V, Perello R (2014) Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial. Emerg Med J 31(9):706–713. https://doi.org/10.1136/emermed-2013-202526

    Article  PubMed  Google Scholar 

  33. Makhoul N, Riad T, Friedstrom S, Zveibil F (1997) Frusemide in pulmonary oedema: continuous versus intermittent. Clin Intensive Care 8(6):273–276

    Article  Google Scholar 

  34. Malkiwodeyar PK, Hiregoudar N, Kabade D, Hasabi I (2017) Continuous versus bolus dosing of furosemide in the treatment of patients with acute decompensated heart failure. Sch J Applied Med Sci 5(9B):3551–3556. https://doi.org/10.21276/sjams.2017.5.9.17

    Article  Google Scholar 

  35. Palazzuoli A, Pellegrini M, Ruocco G, Martini G, Franci B, Campagna MS, Gilleman M, Nuti R, McCullough PA, Ronco C (2014) Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care (London, England) 18(3):R134. https://doi.org/10.1186/cc13952

    Article  Google Scholar 

  36. Raghuraman M, Saravanavel A, Jayasingh K (2015) A comparative study of continuous infusion of frusemide vs intermittent bolus administration in congestive heart failure. Int J Health Sci Res 5(8):162–167

    Google Scholar 

  37. Shah RA, Subban V, Lakshmanan A, Narayanan S, Udhayakumaran K, Pakshirajan B, Krishnamoorthy J, Latchumanadhas K, Janakiraman E, Mullasari AS (2014) A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure. Indian Heart J 66(3):309–316. https://doi.org/10.1016/j.ihj.2014.03.006

    Article  PubMed  PubMed Central  Google Scholar 

  38. Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB (2010) Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 16(3):188–193. https://doi.org/10.1016/j.cardfail.2009.11.005

    Article  CAS  PubMed  Google Scholar 

  39. Wang Y, Tian B, Xue L (2016) A comparative study of continuous and intermittent administration of furosemide in acute decompensated heart failure. J Clin Med 3(41):8154–8155. https://doi.org/10.16281/j.cnki.jocml.2016.41.044

    Article  Google Scholar 

  40. Yayla C, Akyel A, Canpolat U, Gayretli Yayla K, Eyiol A, Akboga MK, Turkoglu S, Tavil Y, Boyaci B, Cengel A (2015) Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure. Herz 40(8):1115–1120. https://doi.org/10.1007/s00059-015-4327-y

    Article  PubMed  Google Scholar 

  41. Ragab D, Taema KM, Farouk W, Saad M (2018) Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: effect on thoracic fluid content. Egypt Heart J 70(2):65–70. https://doi.org/10.1016/j.ehj.2017.12.005

    Article  PubMed  Google Scholar 

  42. Wencker D (2007) Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure. Curr Heart Fail Rep 4(3):134–138

    Article  PubMed  Google Scholar 

  43. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276(8):637–639

    Article  CAS  PubMed  Google Scholar 

  44. Kuriyama A, Umakoshi N, Sun R (2017) Prophylactic corticosteroids for prevention of postextubation stridor and reintubation in adults: a systematic review and meta-analysis. Chest 151(5):1002–1010. https://doi.org/10.1016/j.chest.2017.02.017

    Article  PubMed  Google Scholar 

  45. Kuriyama A, Endo K (2018) Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Support Care Cancer 26(4):1051–1059. https://doi.org/10.1007/s00520-017-4028-6

    Article  PubMed  Google Scholar 

  46. Kuriyama A, Aga M, Maeda H (2018) Topical benzydamine hydrochloride for prevention of postoperative sore throat in adults undergoing tracheal intubation for elective surgery: a systematic review and meta-analysis. Anaesthesia 73(7):889–900. https://doi.org/10.1111/anae.14224

    Article  CAS  PubMed  Google Scholar 

  47. Kuriyama A, Maeda H, Sun R, Aga M (2018) Topical application of corticosteroids to tracheal tubes to prevent postoperative sore throat in adults undergoing tracheal intubation: a systematic review and meta-analysis. Anaesthesia. https://doi.org/10.1111/anae.14273

  48. Kuriyama A, Katsura M, Urushidani S, Takada T (2018) Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials. Ann Transl Med 6(11):206. https://doi.org/10.21037/atm.2018.05.41

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emergency and Critical Care Center, Kurashiki Central Hospital, 1-1-1 Miwa Kurashiki, Okayama, 710-8602, Japan

    Akira Kuriyama & Seigo Urushidani

Authors
  1. Akira Kuriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seigo Urushidani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akira Kuriyama.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Electronic supplementary materials

Supplemental Figure 1

Study selection. (PNG 241 kb)

High resolution image (TIF 354 kb)

Supplemental Figure 2

Urine output at 24 h (mL). (PNG 145 kb)

High resolution image (TIF 235 kb)

Supplementary Table 1

(DOC 27 kb)

Supplementary Table 2

(DOC 68 kb)

ESM 1

(DOC 63 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuriyama, A., Urushidani, S. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev 24, 31–39 (2019). https://doi.org/10.1007/s10741-018-9727-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-018-9727-7

Keywords

Search

Navigation